🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of sitagli...
Status
Completed
Location
Multiple Locations
Start Date
2008-01-15
Trial ID
NCT00541450
The investigators aim is to conduct a double blind randomized clinical tria...
Status
Completed
Location
Gynecology and Obstetric, Hayatabad Medical Complex
Start Date
2021-05-03
Trial ID
NCT04867252
Oral hypoglycemic agents encompass the mainstay of treatment in the majorit...
Status
Completed
Location
Tehran University of Medical Sciences
Start Date
2011-07
Trial ID
NCT01593371
Treatments Being Tested
The purpose of this study is to assess the hypothesis that treatment with s...
Status
Completed
Location
Multiple Locations
Start Date
2010-10-08
Trial ID
NCT01217073
Treatments Being Tested
The treatment of type 2 diabetes mellitus often requires the use of one or ...
Status
Unknown
Location
IRCCS Policlinico S. Matteo Foundation
Start Date
2013-06
Trial ID
NCT01895569
Treatments Being Tested
There are numerous possible reasons why it could be speculated that HbA1c v...
Status
Active Not Recruiting
Location
Hamad Medical Corporation
Start Date
2016-11
Trial ID
NCT02879409
Treatments Being Tested
The purpose of this study is to assess the pioglitazone plus alogliptin plu...
Status
Completed
Location
The Catholic University of Korea, Bucheon, St. Marys Hospital
Start Date
2020-02-11
Trial ID
NCT03499704
Treatments Being Tested
Oral hypoglycemic agents, along with dietary modification and exercise enco...
Status
Completed
Location
Diabetes Clinic, Vali-Asr Hospital, Tehran University of Medical Sciences
Start Date
2012-01
Trial ID
NCT02027103
Treatments Being Tested